BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Neo-Kidney Augment / REACT (Rilparencel) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Neo-Kidney Augment / REACT (Rilparencel)\
 , from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05099770-917@assetmemo.bio
DTSTAMP:20261121T005709Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:Neo-Kidney Augment / REACT (Rilparencel): Phase 3 readout est. (NCT
 05099770)
DESCRIPTION:Neo-Kidney Augment / REACT (Rilparencel)\, phase 3\, Chronic Ki
 dney Disease.\nStudy: Proact: A Study of REACT in Subjects With Type 2 Dia
 betes Mellitus and Chronic Kidney Disease\nEstimated primary completion: D
 ecember 2029. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/rilpare
 ncel#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NC
 T05099770
URL:https://assetmemo.bio/drug/rilparencel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
